- Home
- FLUX vs LGVN Comparison
FLUX vs LGVN Comparison
Compare FLUX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- LGVN
- Stock Information
- Founded
- FLUX N/A
- LGVN 2014
- Country
- FLUX United States
- LGVN United States
- Employees
- FLUX N/A
- LGVN N/A
- Industry
- FLUX Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- FLUX Miscellaneous
- LGVN Health Care
- Exchange
- FLUX Nasdaq
- LGVN Nasdaq
- Market Cap
- FLUX 25.4M
- LGVN 23.4M
- IPO Year
- FLUX N/A
- LGVN 2021
- Fundamental
- Price
- FLUX $1.83
- LGVN $1.67
- Analyst Decision
- FLUX Strong Buy
- LGVN Strong Buy
- Analyst Count
- FLUX 2
- LGVN 3
- Target Price
- FLUX $6.00
- LGVN $8.67
- AVG Volume (30 Days)
- FLUX 154.8K
- LGVN 827.1K
- Earning Date
- FLUX 08-15-2025
- LGVN 08-13-2025
- Dividend Yield
- FLUX N/A
- LGVN N/A
- EPS Growth
- FLUX N/A
- LGVN N/A
- EPS
- FLUX N/A
- LGVN N/A
- Revenue
- FLUX $63,074,000.00
- LGVN $2,225,000.00
- Revenue This Year
- FLUX $11.10
- LGVN N/A
- Revenue Next Year
- FLUX $12.66
- LGVN $51.48
- P/E Ratio
- FLUX N/A
- LGVN N/A
- Revenue Growth
- FLUX N/A
- LGVN 127.50
- 52 Week Low
- FLUX $1.15
- LGVN $1.14
- 52 Week High
- FLUX $3.99
- LGVN $4.29
- Technical
- Relative Strength Index (RSI)
- FLUX 48.43
- LGVN 63.06
- Support Level
- FLUX $1.88
- LGVN $1.43
- Resistance Level
- FLUX $2.15
- LGVN $1.80
- Average True Range (ATR)
- FLUX 0.22
- LGVN 0.15
- MACD
- FLUX -0.02
- LGVN 0.02
- Stochastic Oscillator
- FLUX 16.25
- LGVN 72.92
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.